Barcelona Macula Foundation: Clinical Trials

1 trial sponsored by Barcelona Macula Foundation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Barcelona Macula Foundation: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor
0.5mg aflibercept - Wet Macular Degeneration
Phase 4CompletedBarcelona Macula Foundation462013-07-012018-11-23

Conditions studied

Wet Macular Degeneration (1)

Interventions

aflibercept (1)

Countries

Spain (1)

Top investigators

Carlos Juan Donate, MD (1)  ·  Francisco Cabrera, MD (1)  ·  Javier Araiz, MD (1)  ·  Jordi Mones, MD PhD (1)  ·  Jose Luis Olea, MD (1)  ·  Jose Maria Ruiz-Moreno, MD (1)  ·  Laura Sarasols, MD (1)